| Old | New | Differences | |
|---|---|---|---|
| 1 | - | ||
| 1 | + | CALIFORNIA LEGISLATURE 20252026 REGULAR SESSION Assembly Bill No. 423Introduced by Assembly Member DaviesFebruary 05, 2025 An act to amend Section 11834.26 of the Health and Safety Code, relating to alcohol and drug programs. LEGISLATIVE COUNSEL'S DIGESTAB 423, as introduced, Davies. Alcohol and drug recovery or treatment facilities: discharge and continuing care planning.Existing law provides for the licensure and regulation of adult alcoholism or drug abuse recovery and treatment facilities by the State Department of Health Care Services. Existing law requires a licensee to provide recovery, treatment, or detoxification services. Existing law authorizes the department to adopt regulations requiring records and procedures that are appropriate for each of those services, including, among others, discharge and continuing care planning. This bill would instead require the department to adopt regulations requiring discharge and continuing care planning that are appropriate for each of the aforementioned services. The bill would require the department to adopt regulations requiring a licensee to, among other things, develop a plan to help the patient return to their home community at the conclusion of treatment, as specified, and schedule for the patient a follow-up meeting with a mental health or substance use disorder professional to occur no more than 7 days after discharge. Digest Key Vote: MAJORITY Appropriation: NO Fiscal Committee: YES Local Program: NO Bill TextThe people of the State of California do enact as follows:SECTION 1. Section 11834.26 of the Health and Safety Code is amended to read:11834.26. (a) The licensee shall provide at least one of the following nonmedical services:(1) Recovery services.(2) Treatment services.(3) Detoxification services.(b) The department shall adopt regulations requiring records and procedures that are appropriate for each of the services specified in subdivision (a). The records and procedures may include all of the following:(1) Admission criteria.(2) Intake process.(3) Assessments.(4) Recovery, treatment, or detoxification planning.(5) Referral.(6) Documentation of provision of recovery, treatment, or detoxification services.(7)Discharge and continuing care planning.(8)(7) Indicators of recovery, treatment, or detoxification outcomes.(c) A licensee shall not deny admission to any individual based solely on the individual having a valid prescription from a licensed health care professional for a medication approved by the federal Food and Drug Administration for the purpose of narcotic replacement treatment or medication-assisted treatment of substance use disorders.(d) A licensee shall develop a plan to address when a resident relapses, including when a resident is on the licensed premises after consuming alcohol or using illegal drugs. The plan shall include details of how the treatment stay and treatment plan of the resident will be adjusted to address the relapse episode and how the resident will be treated and supervised while under the influence of alcohol or illegal drugs, as well as discharge and continuing care planning, including when a licensee determines that a resident requires services beyond the scope of the licensee. This subdivision does not require a licensee to discharge a resident.(e) The department shall have the authority to implement subdivisions (d) and (f) by bulletin or all-county or all-provider letter, after stakeholder input, until regulations are promulgated. The department shall promulgate regulations to implement subdivisions (d) and (f) no later than July 1, 2024.(f) (1) A licensee shall, at all times, maintain at least two unexpired doses of naloxone hydrochloride, or any other opioid antagonist that is approved by the United States Food and Drug Administration for treatment of an opioid overdose, on the premises and shall, at all times, have at least one staff member on the premises who knows the specific location of the naloxone hydrochloride, or other opioid antagonist that is approved by the United States Food and Drug Administration for treatment of an opioid overdose, and who has been trained on the administration of naloxone hydrochloride, or the other opioid antagonist that is approved by the United States Food and Drug Administration for treatment of an opioid overdose, in accordance with the training requirements set forth by the department. Proof of completion of training on the administration of naloxone hydrochloride, or other opioid antagonist that is approved by the United States Food and Drug Administration for treatment of an opioid overdose, shall be documented in the staff members individual personnel file.(2) A trained staff member shall not be liable for damages in a civil action or subject to criminal prosecution for the administration, in good faith, of naloxone hydrochloride, or any other opioid antagonist that is approved by the United States Food and Drug Administration for treatment of an opioid overdose, to a person appearing to experience an opioid-related overdose. This paragraph shall not apply in a case where the person who renders emergency care treatment by the use of naloxone hydrochloride, or any other opioid antagonist that is approved by the United States Food and Drug Administration for treatment of an opioid overdose, acts with gross negligence or engages in willful and wanton misconduct.(g) In the development of regulations implementing this section, the written record requirements shall be modified or adapted for social model programs.(h) The department shall adopt regulations requiring discharge and continuing care planning that are appropriate for each of the services specified in subdivision (a). The regulations shall require, at a minimum, a licensee to do all of the following: (1) Develop a plan to help the patient return to their home community at the conclusion of treatment, whether the home community is in this state or out of state. (2) Share information on the patients progress with the administration and providers of the follow-up facility if the patient is transferring to another treatment facility. (3) Ensure that the facility that the patient is being transferred to also provides medication-assisted treatment if a patient is using medication-assisted treatment.(4) Ensure that the patients emergency contact has been made aware of all travel arrangements if the patient is not transferring to another facility.(5) Ensure that a patients medications have easy-to-understand written information and instructions on dosages to take, if necessary, and include information about prior medications the patient has been prescribed and why that treatment course was discontinued.(6) Schedule for the patient a follow-up meeting with a mental health or substance use disorder professional to occur no more than seven days after discharge. | |
| 2 | 2 | ||
| 3 | - | ||
| 3 | + | CALIFORNIA LEGISLATURE 20252026 REGULAR SESSION Assembly Bill No. 423Introduced by Assembly Member DaviesFebruary 05, 2025 An act to amend Section 11834.26 of the Health and Safety Code, relating to alcohol and drug programs. LEGISLATIVE COUNSEL'S DIGESTAB 423, as introduced, Davies. Alcohol and drug recovery or treatment facilities: discharge and continuing care planning.Existing law provides for the licensure and regulation of adult alcoholism or drug abuse recovery and treatment facilities by the State Department of Health Care Services. Existing law requires a licensee to provide recovery, treatment, or detoxification services. Existing law authorizes the department to adopt regulations requiring records and procedures that are appropriate for each of those services, including, among others, discharge and continuing care planning. This bill would instead require the department to adopt regulations requiring discharge and continuing care planning that are appropriate for each of the aforementioned services. The bill would require the department to adopt regulations requiring a licensee to, among other things, develop a plan to help the patient return to their home community at the conclusion of treatment, as specified, and schedule for the patient a follow-up meeting with a mental health or substance use disorder professional to occur no more than 7 days after discharge. Digest Key Vote: MAJORITY Appropriation: NO Fiscal Committee: YES Local Program: NO | |
| 4 | 4 | ||
| 5 | - | Amended IN Assembly April 02, 2025 | |
| 6 | 5 | ||
| 7 | - | Amended IN Assembly April 02, 2025 | |
| 6 | + | ||
| 7 | + | ||
| 8 | 8 | ||
| 9 | 9 | CALIFORNIA LEGISLATURE 20252026 REGULAR SESSION | |
| 10 | 10 | ||
| 11 | 11 | Assembly Bill | |
| 12 | 12 | ||
| 13 | 13 | No. 423 | |
| 14 | 14 | ||
| 15 | 15 | Introduced by Assembly Member DaviesFebruary 05, 2025 | |
| 16 | 16 | ||
| 17 | 17 | Introduced by Assembly Member Davies | |
| 18 | 18 | February 05, 2025 | |
| 19 | 19 | ||
| 20 | - | An act to amend Section 11834.26 | |
| 20 | + | An act to amend Section 11834.26 of the Health and Safety Code, relating to alcohol and drug programs. | |
| 21 | 21 | ||
| 22 | 22 | LEGISLATIVE COUNSEL'S DIGEST | |
| 23 | 23 | ||
| 24 | 24 | ## LEGISLATIVE COUNSEL'S DIGEST | |
| 25 | 25 | ||
| 26 | - | AB 423, as | |
| 26 | + | AB 423, as introduced, Davies. Alcohol and drug recovery or treatment facilities: discharge and continuing care planning. | |
| 27 | 27 | ||
| 28 | - | Existing law grants the sole authority in state government to the State Department of Health Care Services to certify alcohol or other drug programs and to license adult alcoholism or drug abuse recovery or treatment facilities. Existing law requires certified programs and licensed facilities to disclose to the department if any of its agents, partners, directors, officers, or owners own or have a financial interest in a recovery residence and whether it has contractual relationships with entities that provide recovery services to clients of certified programs or licensed facilities if the entity is not a part of a certified program or a licensed facility. Existing law defines recovery residence as a residential dwelling that provides primary housing for individuals who seek a cooperative living arrangement that supports personal recovery from a substance use disorder and that does not require licensure by the department or does not provide licensable services.This bill would require a business-operated recovery residence to register its location with the department. The bill would define a business-operated recovery residence as a recovery residence in which a business, in exchange for compensation, provides more than one service beyond those of a typical tenancy arrangement to more than one occupant, including, but not limited to, drug testing, supervision, scheduling, rule setting, rule enforcement, room assignment, entertainment, gym memberships, transportation, laundry, or meal preparation and coordination.Existing law provides for the licensure and regulation of adult alcoholism or drug abuse recovery and treatment facilities by the State Department of Health Care Services. Existing law requires a licensee to provide recovery, treatment, or detoxification services. Existing law authorizes the department to adopt regulations requiring records and procedures that are appropriate for each of those services, including, among others, discharge and continuing care planning. This bill would instead require the department to adopt regulations requiring discharge and continuing care planning that are appropriate for each of the aforementioned services. The bill would require the department to adopt regulations requiring a licensee to, among other things, develop a plan to help the patient return to their home community at the conclusion of treatment, as specified, and schedule for the patient a follow-up meeting with a mental health or substance use disorder professional to occur no more than 7 days after discharge. | |
| 29 | - | ||
| 30 | - | Existing law grants the sole authority in state government to the State Department of Health Care Services to certify alcohol or other drug programs and to license adult alcoholism or drug abuse recovery or treatment facilities. Existing law requires certified programs and licensed facilities to disclose to the department if any of its agents, partners, directors, officers, or owners own or have a financial interest in a recovery residence and whether it has contractual relationships with entities that provide recovery services to clients of certified programs or licensed facilities if the entity is not a part of a certified program or a licensed facility. Existing law defines recovery residence as a residential dwelling that provides primary housing for individuals who seek a cooperative living arrangement that supports personal recovery from a substance use disorder and that does not require licensure by the department or does not provide licensable services. | |
| 31 | - | ||
| 32 | - | This bill would require a business-operated recovery residence to register its location with the department. The bill would define a business-operated recovery residence as a recovery residence in which a business, in exchange for compensation, provides more than one service beyond those of a typical tenancy arrangement to more than one occupant, including, but not limited to, drug testing, supervision, scheduling, rule setting, rule enforcement, room assignment, entertainment, gym memberships, transportation, laundry, or meal preparation and coordination. | |
| 28 | + | Existing law provides for the licensure and regulation of adult alcoholism or drug abuse recovery and treatment facilities by the State Department of Health Care Services. Existing law requires a licensee to provide recovery, treatment, or detoxification services. Existing law authorizes the department to adopt regulations requiring records and procedures that are appropriate for each of those services, including, among others, discharge and continuing care planning. This bill would instead require the department to adopt regulations requiring discharge and continuing care planning that are appropriate for each of the aforementioned services. The bill would require the department to adopt regulations requiring a licensee to, among other things, develop a plan to help the patient return to their home community at the conclusion of treatment, as specified, and schedule for the patient a follow-up meeting with a mental health or substance use disorder professional to occur no more than 7 days after discharge. | |
| 33 | 29 | ||
| 34 | 30 | Existing law provides for the licensure and regulation of adult alcoholism or drug abuse recovery and treatment facilities by the State Department of Health Care Services. Existing law requires a licensee to provide recovery, treatment, or detoxification services. Existing law authorizes the department to adopt regulations requiring records and procedures that are appropriate for each of those services, including, among others, discharge and continuing care planning. | |
| 35 | 31 | ||
| 36 | - | ||
| 37 | - | ||
| 38 | 32 | This bill would instead require the department to adopt regulations requiring discharge and continuing care planning that are appropriate for each of the aforementioned services. The bill would require the department to adopt regulations requiring a licensee to, among other things, develop a plan to help the patient return to their home community at the conclusion of treatment, as specified, and schedule for the patient a follow-up meeting with a mental health or substance use disorder professional to occur no more than 7 days after discharge. | |
| 39 | - | ||
| 40 | - | ||
| 41 | 33 | ||
| 42 | 34 | ## Digest Key | |
| 43 | 35 | ||
| 44 | 36 | ## Bill Text | |
| 45 | 37 | ||
| 46 | - | The people of the State of California do enact as follows:SECTION 1. | |
| 38 | + | The people of the State of California do enact as follows:SECTION 1. Section 11834.26 of the Health and Safety Code is amended to read:11834.26. (a) The licensee shall provide at least one of the following nonmedical services:(1) Recovery services.(2) Treatment services.(3) Detoxification services.(b) The department shall adopt regulations requiring records and procedures that are appropriate for each of the services specified in subdivision (a). The records and procedures may include all of the following:(1) Admission criteria.(2) Intake process.(3) Assessments.(4) Recovery, treatment, or detoxification planning.(5) Referral.(6) Documentation of provision of recovery, treatment, or detoxification services.(7)Discharge and continuing care planning.(8)(7) Indicators of recovery, treatment, or detoxification outcomes.(c) A licensee shall not deny admission to any individual based solely on the individual having a valid prescription from a licensed health care professional for a medication approved by the federal Food and Drug Administration for the purpose of narcotic replacement treatment or medication-assisted treatment of substance use disorders.(d) A licensee shall develop a plan to address when a resident relapses, including when a resident is on the licensed premises after consuming alcohol or using illegal drugs. The plan shall include details of how the treatment stay and treatment plan of the resident will be adjusted to address the relapse episode and how the resident will be treated and supervised while under the influence of alcohol or illegal drugs, as well as discharge and continuing care planning, including when a licensee determines that a resident requires services beyond the scope of the licensee. This subdivision does not require a licensee to discharge a resident.(e) The department shall have the authority to implement subdivisions (d) and (f) by bulletin or all-county or all-provider letter, after stakeholder input, until regulations are promulgated. The department shall promulgate regulations to implement subdivisions (d) and (f) no later than July 1, 2024.(f) (1) A licensee shall, at all times, maintain at least two unexpired doses of naloxone hydrochloride, or any other opioid antagonist that is approved by the United States Food and Drug Administration for treatment of an opioid overdose, on the premises and shall, at all times, have at least one staff member on the premises who knows the specific location of the naloxone hydrochloride, or other opioid antagonist that is approved by the United States Food and Drug Administration for treatment of an opioid overdose, and who has been trained on the administration of naloxone hydrochloride, or the other opioid antagonist that is approved by the United States Food and Drug Administration for treatment of an opioid overdose, in accordance with the training requirements set forth by the department. Proof of completion of training on the administration of naloxone hydrochloride, or other opioid antagonist that is approved by the United States Food and Drug Administration for treatment of an opioid overdose, shall be documented in the staff members individual personnel file.(2) A trained staff member shall not be liable for damages in a civil action or subject to criminal prosecution for the administration, in good faith, of naloxone hydrochloride, or any other opioid antagonist that is approved by the United States Food and Drug Administration for treatment of an opioid overdose, to a person appearing to experience an opioid-related overdose. This paragraph shall not apply in a case where the person who renders emergency care treatment by the use of naloxone hydrochloride, or any other opioid antagonist that is approved by the United States Food and Drug Administration for treatment of an opioid overdose, acts with gross negligence or engages in willful and wanton misconduct.(g) In the development of regulations implementing this section, the written record requirements shall be modified or adapted for social model programs.(h) The department shall adopt regulations requiring discharge and continuing care planning that are appropriate for each of the services specified in subdivision (a). The regulations shall require, at a minimum, a licensee to do all of the following: (1) Develop a plan to help the patient return to their home community at the conclusion of treatment, whether the home community is in this state or out of state. (2) Share information on the patients progress with the administration and providers of the follow-up facility if the patient is transferring to another treatment facility. (3) Ensure that the facility that the patient is being transferred to also provides medication-assisted treatment if a patient is using medication-assisted treatment.(4) Ensure that the patients emergency contact has been made aware of all travel arrangements if the patient is not transferring to another facility.(5) Ensure that a patients medications have easy-to-understand written information and instructions on dosages to take, if necessary, and include information about prior medications the patient has been prescribed and why that treatment course was discontinued.(6) Schedule for the patient a follow-up meeting with a mental health or substance use disorder professional to occur no more than seven days after discharge. | |
| 47 | 39 | ||
| 48 | 40 | The people of the State of California do enact as follows: | |
| 49 | 41 | ||
| 50 | 42 | ## The people of the State of California do enact as follows: | |
| 51 | 43 | ||
| 52 | - | SECTION 1. Section | |
| 44 | + | SECTION 1. Section 11834.26 of the Health and Safety Code is amended to read:11834.26. (a) The licensee shall provide at least one of the following nonmedical services:(1) Recovery services.(2) Treatment services.(3) Detoxification services.(b) The department shall adopt regulations requiring records and procedures that are appropriate for each of the services specified in subdivision (a). The records and procedures may include all of the following:(1) Admission criteria.(2) Intake process.(3) Assessments.(4) Recovery, treatment, or detoxification planning.(5) Referral.(6) Documentation of provision of recovery, treatment, or detoxification services.(7)Discharge and continuing care planning.(8)(7) Indicators of recovery, treatment, or detoxification outcomes.(c) A licensee shall not deny admission to any individual based solely on the individual having a valid prescription from a licensed health care professional for a medication approved by the federal Food and Drug Administration for the purpose of narcotic replacement treatment or medication-assisted treatment of substance use disorders.(d) A licensee shall develop a plan to address when a resident relapses, including when a resident is on the licensed premises after consuming alcohol or using illegal drugs. The plan shall include details of how the treatment stay and treatment plan of the resident will be adjusted to address the relapse episode and how the resident will be treated and supervised while under the influence of alcohol or illegal drugs, as well as discharge and continuing care planning, including when a licensee determines that a resident requires services beyond the scope of the licensee. This subdivision does not require a licensee to discharge a resident.(e) The department shall have the authority to implement subdivisions (d) and (f) by bulletin or all-county or all-provider letter, after stakeholder input, until regulations are promulgated. The department shall promulgate regulations to implement subdivisions (d) and (f) no later than July 1, 2024.(f) (1) A licensee shall, at all times, maintain at least two unexpired doses of naloxone hydrochloride, or any other opioid antagonist that is approved by the United States Food and Drug Administration for treatment of an opioid overdose, on the premises and shall, at all times, have at least one staff member on the premises who knows the specific location of the naloxone hydrochloride, or other opioid antagonist that is approved by the United States Food and Drug Administration for treatment of an opioid overdose, and who has been trained on the administration of naloxone hydrochloride, or the other opioid antagonist that is approved by the United States Food and Drug Administration for treatment of an opioid overdose, in accordance with the training requirements set forth by the department. Proof of completion of training on the administration of naloxone hydrochloride, or other opioid antagonist that is approved by the United States Food and Drug Administration for treatment of an opioid overdose, shall be documented in the staff members individual personnel file.(2) A trained staff member shall not be liable for damages in a civil action or subject to criminal prosecution for the administration, in good faith, of naloxone hydrochloride, or any other opioid antagonist that is approved by the United States Food and Drug Administration for treatment of an opioid overdose, to a person appearing to experience an opioid-related overdose. This paragraph shall not apply in a case where the person who renders emergency care treatment by the use of naloxone hydrochloride, or any other opioid antagonist that is approved by the United States Food and Drug Administration for treatment of an opioid overdose, acts with gross negligence or engages in willful and wanton misconduct.(g) In the development of regulations implementing this section, the written record requirements shall be modified or adapted for social model programs.(h) The department shall adopt regulations requiring discharge and continuing care planning that are appropriate for each of the services specified in subdivision (a). The regulations shall require, at a minimum, a licensee to do all of the following: (1) Develop a plan to help the patient return to their home community at the conclusion of treatment, whether the home community is in this state or out of state. (2) Share information on the patients progress with the administration and providers of the follow-up facility if the patient is transferring to another treatment facility. (3) Ensure that the facility that the patient is being transferred to also provides medication-assisted treatment if a patient is using medication-assisted treatment.(4) Ensure that the patients emergency contact has been made aware of all travel arrangements if the patient is not transferring to another facility.(5) Ensure that a patients medications have easy-to-understand written information and instructions on dosages to take, if necessary, and include information about prior medications the patient has been prescribed and why that treatment course was discontinued.(6) Schedule for the patient a follow-up meeting with a mental health or substance use disorder professional to occur no more than seven days after discharge. | |
| 53 | 45 | ||
| 54 | - | SECTION 1. Section | |
| 46 | + | SECTION 1. Section 11834.26 of the Health and Safety Code is amended to read: | |
| 55 | 47 | ||
| 56 | 48 | ### SECTION 1. | |
| 57 | 49 | ||
| 58 | - | ||
| 50 | + | 11834.26. (a) The licensee shall provide at least one of the following nonmedical services:(1) Recovery services.(2) Treatment services.(3) Detoxification services.(b) The department shall adopt regulations requiring records and procedures that are appropriate for each of the services specified in subdivision (a). The records and procedures may include all of the following:(1) Admission criteria.(2) Intake process.(3) Assessments.(4) Recovery, treatment, or detoxification planning.(5) Referral.(6) Documentation of provision of recovery, treatment, or detoxification services.(7)Discharge and continuing care planning.(8)(7) Indicators of recovery, treatment, or detoxification outcomes.(c) A licensee shall not deny admission to any individual based solely on the individual having a valid prescription from a licensed health care professional for a medication approved by the federal Food and Drug Administration for the purpose of narcotic replacement treatment or medication-assisted treatment of substance use disorders.(d) A licensee shall develop a plan to address when a resident relapses, including when a resident is on the licensed premises after consuming alcohol or using illegal drugs. The plan shall include details of how the treatment stay and treatment plan of the resident will be adjusted to address the relapse episode and how the resident will be treated and supervised while under the influence of alcohol or illegal drugs, as well as discharge and continuing care planning, including when a licensee determines that a resident requires services beyond the scope of the licensee. This subdivision does not require a licensee to discharge a resident.(e) The department shall have the authority to implement subdivisions (d) and (f) by bulletin or all-county or all-provider letter, after stakeholder input, until regulations are promulgated. The department shall promulgate regulations to implement subdivisions (d) and (f) no later than July 1, 2024.(f) (1) A licensee shall, at all times, maintain at least two unexpired doses of naloxone hydrochloride, or any other opioid antagonist that is approved by the United States Food and Drug Administration for treatment of an opioid overdose, on the premises and shall, at all times, have at least one staff member on the premises who knows the specific location of the naloxone hydrochloride, or other opioid antagonist that is approved by the United States Food and Drug Administration for treatment of an opioid overdose, and who has been trained on the administration of naloxone hydrochloride, or the other opioid antagonist that is approved by the United States Food and Drug Administration for treatment of an opioid overdose, in accordance with the training requirements set forth by the department. Proof of completion of training on the administration of naloxone hydrochloride, or other opioid antagonist that is approved by the United States Food and Drug Administration for treatment of an opioid overdose, shall be documented in the staff members individual personnel file.(2) A trained staff member shall not be liable for damages in a civil action or subject to criminal prosecution for the administration, in good faith, of naloxone hydrochloride, or any other opioid antagonist that is approved by the United States Food and Drug Administration for treatment of an opioid overdose, to a person appearing to experience an opioid-related overdose. This paragraph shall not apply in a case where the person who renders emergency care treatment by the use of naloxone hydrochloride, or any other opioid antagonist that is approved by the United States Food and Drug Administration for treatment of an opioid overdose, acts with gross negligence or engages in willful and wanton misconduct.(g) In the development of regulations implementing this section, the written record requirements shall be modified or adapted for social model programs.(h) The department shall adopt regulations requiring discharge and continuing care planning that are appropriate for each of the services specified in subdivision (a). The regulations shall require, at a minimum, a licensee to do all of the following: (1) Develop a plan to help the patient return to their home community at the conclusion of treatment, whether the home community is in this state or out of state. (2) Share information on the patients progress with the administration and providers of the follow-up facility if the patient is transferring to another treatment facility. (3) Ensure that the facility that the patient is being transferred to also provides medication-assisted treatment if a patient is using medication-assisted treatment.(4) Ensure that the patients emergency contact has been made aware of all travel arrangements if the patient is not transferring to another facility.(5) Ensure that a patients medications have easy-to-understand written information and instructions on dosages to take, if necessary, and include information about prior medications the patient has been prescribed and why that treatment course was discontinued.(6) Schedule for the patient a follow-up meeting with a mental health or substance use disorder professional to occur no more than seven days after discharge. | |
| 59 | 51 | ||
| 60 | - | ||
| 52 | + | 11834.26. (a) The licensee shall provide at least one of the following nonmedical services:(1) Recovery services.(2) Treatment services.(3) Detoxification services.(b) The department shall adopt regulations requiring records and procedures that are appropriate for each of the services specified in subdivision (a). The records and procedures may include all of the following:(1) Admission criteria.(2) Intake process.(3) Assessments.(4) Recovery, treatment, or detoxification planning.(5) Referral.(6) Documentation of provision of recovery, treatment, or detoxification services.(7)Discharge and continuing care planning.(8)(7) Indicators of recovery, treatment, or detoxification outcomes.(c) A licensee shall not deny admission to any individual based solely on the individual having a valid prescription from a licensed health care professional for a medication approved by the federal Food and Drug Administration for the purpose of narcotic replacement treatment or medication-assisted treatment of substance use disorders.(d) A licensee shall develop a plan to address when a resident relapses, including when a resident is on the licensed premises after consuming alcohol or using illegal drugs. The plan shall include details of how the treatment stay and treatment plan of the resident will be adjusted to address the relapse episode and how the resident will be treated and supervised while under the influence of alcohol or illegal drugs, as well as discharge and continuing care planning, including when a licensee determines that a resident requires services beyond the scope of the licensee. This subdivision does not require a licensee to discharge a resident.(e) The department shall have the authority to implement subdivisions (d) and (f) by bulletin or all-county or all-provider letter, after stakeholder input, until regulations are promulgated. The department shall promulgate regulations to implement subdivisions (d) and (f) no later than July 1, 2024.(f) (1) A licensee shall, at all times, maintain at least two unexpired doses of naloxone hydrochloride, or any other opioid antagonist that is approved by the United States Food and Drug Administration for treatment of an opioid overdose, on the premises and shall, at all times, have at least one staff member on the premises who knows the specific location of the naloxone hydrochloride, or other opioid antagonist that is approved by the United States Food and Drug Administration for treatment of an opioid overdose, and who has been trained on the administration of naloxone hydrochloride, or the other opioid antagonist that is approved by the United States Food and Drug Administration for treatment of an opioid overdose, in accordance with the training requirements set forth by the department. Proof of completion of training on the administration of naloxone hydrochloride, or other opioid antagonist that is approved by the United States Food and Drug Administration for treatment of an opioid overdose, shall be documented in the staff members individual personnel file.(2) A trained staff member shall not be liable for damages in a civil action or subject to criminal prosecution for the administration, in good faith, of naloxone hydrochloride, or any other opioid antagonist that is approved by the United States Food and Drug Administration for treatment of an opioid overdose, to a person appearing to experience an opioid-related overdose. This paragraph shall not apply in a case where the person who renders emergency care treatment by the use of naloxone hydrochloride, or any other opioid antagonist that is approved by the United States Food and Drug Administration for treatment of an opioid overdose, acts with gross negligence or engages in willful and wanton misconduct.(g) In the development of regulations implementing this section, the written record requirements shall be modified or adapted for social model programs.(h) The department shall adopt regulations requiring discharge and continuing care planning that are appropriate for each of the services specified in subdivision (a). The regulations shall require, at a minimum, a licensee to do all of the following: (1) Develop a plan to help the patient return to their home community at the conclusion of treatment, whether the home community is in this state or out of state. (2) Share information on the patients progress with the administration and providers of the follow-up facility if the patient is transferring to another treatment facility. (3) Ensure that the facility that the patient is being transferred to also provides medication-assisted treatment if a patient is using medication-assisted treatment.(4) Ensure that the patients emergency contact has been made aware of all travel arrangements if the patient is not transferring to another facility.(5) Ensure that a patients medications have easy-to-understand written information and instructions on dosages to take, if necessary, and include information about prior medications the patient has been prescribed and why that treatment course was discontinued.(6) Schedule for the patient a follow-up meeting with a mental health or substance use disorder professional to occur no more than seven days after discharge. | |
| 61 | 53 | ||
| 62 | - | ||
| 54 | + | 11834.26. (a) The licensee shall provide at least one of the following nonmedical services:(1) Recovery services.(2) Treatment services.(3) Detoxification services.(b) The department shall adopt regulations requiring records and procedures that are appropriate for each of the services specified in subdivision (a). The records and procedures may include all of the following:(1) Admission criteria.(2) Intake process.(3) Assessments.(4) Recovery, treatment, or detoxification planning.(5) Referral.(6) Documentation of provision of recovery, treatment, or detoxification services.(7)Discharge and continuing care planning.(8)(7) Indicators of recovery, treatment, or detoxification outcomes.(c) A licensee shall not deny admission to any individual based solely on the individual having a valid prescription from a licensed health care professional for a medication approved by the federal Food and Drug Administration for the purpose of narcotic replacement treatment or medication-assisted treatment of substance use disorders.(d) A licensee shall develop a plan to address when a resident relapses, including when a resident is on the licensed premises after consuming alcohol or using illegal drugs. The plan shall include details of how the treatment stay and treatment plan of the resident will be adjusted to address the relapse episode and how the resident will be treated and supervised while under the influence of alcohol or illegal drugs, as well as discharge and continuing care planning, including when a licensee determines that a resident requires services beyond the scope of the licensee. This subdivision does not require a licensee to discharge a resident.(e) The department shall have the authority to implement subdivisions (d) and (f) by bulletin or all-county or all-provider letter, after stakeholder input, until regulations are promulgated. The department shall promulgate regulations to implement subdivisions (d) and (f) no later than July 1, 2024.(f) (1) A licensee shall, at all times, maintain at least two unexpired doses of naloxone hydrochloride, or any other opioid antagonist that is approved by the United States Food and Drug Administration for treatment of an opioid overdose, on the premises and shall, at all times, have at least one staff member on the premises who knows the specific location of the naloxone hydrochloride, or other opioid antagonist that is approved by the United States Food and Drug Administration for treatment of an opioid overdose, and who has been trained on the administration of naloxone hydrochloride, or the other opioid antagonist that is approved by the United States Food and Drug Administration for treatment of an opioid overdose, in accordance with the training requirements set forth by the department. Proof of completion of training on the administration of naloxone hydrochloride, or other opioid antagonist that is approved by the United States Food and Drug Administration for treatment of an opioid overdose, shall be documented in the staff members individual personnel file.(2) A trained staff member shall not be liable for damages in a civil action or subject to criminal prosecution for the administration, in good faith, of naloxone hydrochloride, or any other opioid antagonist that is approved by the United States Food and Drug Administration for treatment of an opioid overdose, to a person appearing to experience an opioid-related overdose. This paragraph shall not apply in a case where the person who renders emergency care treatment by the use of naloxone hydrochloride, or any other opioid antagonist that is approved by the United States Food and Drug Administration for treatment of an opioid overdose, acts with gross negligence or engages in willful and wanton misconduct.(g) In the development of regulations implementing this section, the written record requirements shall be modified or adapted for social model programs.(h) The department shall adopt regulations requiring discharge and continuing care planning that are appropriate for each of the services specified in subdivision (a). The regulations shall require, at a minimum, a licensee to do all of the following: (1) Develop a plan to help the patient return to their home community at the conclusion of treatment, whether the home community is in this state or out of state. (2) Share information on the patients progress with the administration and providers of the follow-up facility if the patient is transferring to another treatment facility. (3) Ensure that the facility that the patient is being transferred to also provides medication-assisted treatment if a patient is using medication-assisted treatment.(4) Ensure that the patients emergency contact has been made aware of all travel arrangements if the patient is not transferring to another facility.(5) Ensure that a patients medications have easy-to-understand written information and instructions on dosages to take, if necessary, and include information about prior medications the patient has been prescribed and why that treatment course was discontinued.(6) Schedule for the patient a follow-up meeting with a mental health or substance use disorder professional to occur no more than seven days after discharge. | |
| 63 | 55 | ||
| 64 | 56 | ||
| 65 | 57 | ||
| 66 | - | ||
| 58 | + | 11834.26. (a) The licensee shall provide at least one of the following nonmedical services: | |
| 67 | 59 | ||
| 68 | - | (1) | |
| 60 | + | (1) Recovery services. | |
| 69 | 61 | ||
| 70 | - | (2) | |
| 62 | + | (2) Treatment services. | |
| 71 | 63 | ||
| 72 | - | ( | |
| 64 | + | (3) Detoxification services. | |
| 73 | 65 | ||
| 74 | - | ( | |
| 66 | + | (b) The department shall adopt regulations requiring records and procedures that are appropriate for each of the services specified in subdivision (a). The records and procedures may include all of the following: | |
| 75 | 67 | ||
| 76 | - | ||
| 68 | + | (1) Admission criteria. | |
| 77 | 69 | ||
| 78 | - | ( | |
| 70 | + | (2) Intake process. | |
| 79 | 71 | ||
| 80 | - | ( | |
| 72 | + | (3) Assessments. | |
| 81 | 73 | ||
| 82 | - | (f) | |
| 74 | + | (4) Recovery, treatment, or detoxification planning. | |
| 75 | + | ||
| 76 | + | (5) Referral. | |
| 77 | + | ||
| 78 | + | (6) Documentation of provision of recovery, treatment, or detoxification services. | |
| 79 | + | ||
| 80 | + | (7)Discharge and continuing care planning. | |
| 83 | 81 | ||
| 84 | 82 | ||
| 85 | 83 | ||
| 86 | - | (g) For the purposes of this section, recovery both of the following definitions apply: | |
| 87 | - | ||
| 88 | - | (1) Business-operated recovery residence means a recovery residence in which a business, in exchange for compensation, provides more than one service beyond those of a typical tenancy arrangement to more than one occupant, including, but not limited to, drug testing, supervision, scheduling, rule setting, rule enforcement, room assignment, entertainment, gym memberships, transportation, laundry, or meal preparation and coordination. | |
| 89 | - | ||
| 90 | - | (2) Recovery residence means a residential dwelling that provides primary housing for individuals who seek a cooperative living arrangement that supports personal recovery from a substance use disorder and that does not require licensure by the department or does not provide licensable services, pursuant to Chapter 7.5 (commencing with Section 11834.01). A recovery residence may include, but is not limited to, residential dwellings commonly referred to as sober living homes, sober living environments, or unlicensed alcohol and drug free residences. | |
| 91 | - | ||
| 92 | - | ||
| 93 | - | ||
| 94 | - | ||
| 95 | - | ||
| 96 | - | (a)The licensee shall provide at least one of the following nonmedical services: | |
| 97 | - | ||
| 98 | - | ||
| 99 | - | ||
| 100 | - | (1)Recovery services. | |
| 101 | - | ||
| 102 | - | ||
| 103 | - | ||
| 104 | - | (2)Treatment services. | |
| 105 | - | ||
| 106 | - | ||
| 107 | - | ||
| 108 | - | (3)Detoxification services. | |
| 109 | - | ||
| 110 | - | ||
| 111 | - | ||
| 112 | - | (b)The department shall adopt regulations requiring records and procedures that are appropriate for each of the services specified in subdivision (a). The records and procedures may include all of the following: | |
| 113 | - | ||
| 114 | - | ||
| 115 | - | ||
| 116 | - | (1)Admission criteria. | |
| 117 | - | ||
| 118 | - | ||
| 119 | - | ||
| 120 | - | (2)Intake process. | |
| 121 | - | ||
| 122 | - | ||
| 123 | - | ||
| 124 | - | (3)Assessments. | |
| 125 | - | ||
| 126 | - | ||
| 127 | - | ||
| 128 | - | (4)Recovery, treatment, or detoxification planning. | |
| 129 | - | ||
| 130 | - | ||
| 131 | - | ||
| 132 | - | (5)Referral. | |
| 133 | - | ||
| 134 | - | ||
| 135 | - | ||
| 136 | - | (6)Documentation of provision of recovery, treatment, or detoxification services. | |
| 84 | + | (8) | |
| 137 | 85 | ||
| 138 | 86 | ||
| 139 | 87 | ||
| 140 | 88 | (7) Indicators of recovery, treatment, or detoxification outcomes. | |
| 141 | 89 | ||
| 142 | - | ||
| 143 | - | ||
| 144 | 90 | (c) A licensee shall not deny admission to any individual based solely on the individual having a valid prescription from a licensed health care professional for a medication approved by the federal Food and Drug Administration for the purpose of narcotic replacement treatment or medication-assisted treatment of substance use disorders. | |
| 145 | - | ||
| 146 | - | ||
| 147 | 91 | ||
| 148 | 92 | (d) A licensee shall develop a plan to address when a resident relapses, including when a resident is on the licensed premises after consuming alcohol or using illegal drugs. The plan shall include details of how the treatment stay and treatment plan of the resident will be adjusted to address the relapse episode and how the resident will be treated and supervised while under the influence of alcohol or illegal drugs, as well as discharge and continuing care planning, including when a licensee determines that a resident requires services beyond the scope of the licensee. This subdivision does not require a licensee to discharge a resident. | |
| 149 | 93 | ||
| 150 | - | ||
| 151 | - | ||
| 152 | 94 | (e) The department shall have the authority to implement subdivisions (d) and (f) by bulletin or all-county or all-provider letter, after stakeholder input, until regulations are promulgated. The department shall promulgate regulations to implement subdivisions (d) and (f) no later than July 1, 2024. | |
| 153 | - | ||
| 154 | - | ||
| 155 | 95 | ||
| 156 | 96 | (f) (1) A licensee shall, at all times, maintain at least two unexpired doses of naloxone hydrochloride, or any other opioid antagonist that is approved by the United States Food and Drug Administration for treatment of an opioid overdose, on the premises and shall, at all times, have at least one staff member on the premises who knows the specific location of the naloxone hydrochloride, or other opioid antagonist that is approved by the United States Food and Drug Administration for treatment of an opioid overdose, and who has been trained on the administration of naloxone hydrochloride, or the other opioid antagonist that is approved by the United States Food and Drug Administration for treatment of an opioid overdose, in accordance with the training requirements set forth by the department. Proof of completion of training on the administration of naloxone hydrochloride, or other opioid antagonist that is approved by the United States Food and Drug Administration for treatment of an opioid overdose, shall be documented in the staff members individual personnel file. | |
| 157 | 97 | ||
| 158 | - | ||
| 159 | - | ||
| 160 | 98 | (2) A trained staff member shall not be liable for damages in a civil action or subject to criminal prosecution for the administration, in good faith, of naloxone hydrochloride, or any other opioid antagonist that is approved by the United States Food and Drug Administration for treatment of an opioid overdose, to a person appearing to experience an opioid-related overdose. This paragraph shall not apply in a case where the person who renders emergency care treatment by the use of naloxone hydrochloride, or any other opioid antagonist that is approved by the United States Food and Drug Administration for treatment of an opioid overdose, acts with gross negligence or engages in willful and wanton misconduct. | |
| 161 | - | ||
| 162 | - | ||
| 163 | 99 | ||
| 164 | 100 | (g) In the development of regulations implementing this section, the written record requirements shall be modified or adapted for social model programs. | |
| 165 | 101 | ||
| 166 | - | ||
| 167 | - | ||
| 168 | 102 | (h) The department shall adopt regulations requiring discharge and continuing care planning that are appropriate for each of the services specified in subdivision (a). The regulations shall require, at a minimum, a licensee to do all of the following: | |
| 169 | - | ||
| 170 | - | ||
| 171 | 103 | ||
| 172 | 104 | (1) Develop a plan to help the patient return to their home community at the conclusion of treatment, whether the home community is in this state or out of state. | |
| 173 | 105 | ||
| 174 | - | ||
| 175 | - | ||
| 176 | 106 | (2) Share information on the patients progress with the administration and providers of the follow-up facility if the patient is transferring to another treatment facility. | |
| 177 | - | ||
| 178 | - | ||
| 179 | 107 | ||
| 180 | 108 | (3) Ensure that the facility that the patient is being transferred to also provides medication-assisted treatment if a patient is using medication-assisted treatment. | |
| 181 | 109 | ||
| 182 | - | ||
| 183 | - | ||
| 184 | 110 | (4) Ensure that the patients emergency contact has been made aware of all travel arrangements if the patient is not transferring to another facility. | |
| 185 | 111 | ||
| 186 | - | ||
| 187 | - | ||
| 188 | 112 | (5) Ensure that a patients medications have easy-to-understand written information and instructions on dosages to take, if necessary, and include information about prior medications the patient has been prescribed and why that treatment course was discontinued. | |
| 189 | - | ||
| 190 | - | ||
| 191 | 113 | ||
| 192 | 114 | (6) Schedule for the patient a follow-up meeting with a mental health or substance use disorder professional to occur no more than seven days after discharge. |